Top Markets
#1 GALA GALA +32.47%
#2 Fabric Protocol Fabric Protocol +32.28%
#3 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +31.50%
#4 Bitcoin Cash Bitcoin Cash +31.11%
#5 Tutorial Tutorial +30.85%
#6 Zora Zora +24.99%
#7 Arowana Arowana +22.89%
#8 aPriori aPriori +22.63%
#9 Talus Network Talus Network +22.63%
#10 Useless Coin Useless Coin +22.42%
Coin of the day
GALA GALA
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Rangering i aksjer #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Aksjekurs
$1.48
Sist synkronisert: 2025-03-24
Markedsverdi
$59.05M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
GB
Handel Achilles Therapeutics plc (ACHL)

Kategori

Healthcare
Inntekter for Achilles Therapeutics plc (ACHL)
Inntekter i 2026 TTM: 0
Ifølge Achilles Therapeutics plc sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Achilles Therapeutics plc fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH